Dr. Wen-Chin Yang’s Team Successfully Translates Scientific Research into Practice — Innovative Drug Technology Reaches a New Milestone

Congratulations to Dr. Wen-Chin Yang and his team for successfully transforming their scientific research concept into a startup company. Through the continued efforts of the new venture, they have progressed smoothly toward listing on the Emerging Stock Board, achieving an admirable and significant milestone. This remarkable accomplishment is built upon Dr. Yang’s long‑term research foundation at our center, as well as the strong support of the NSTC’s Value Creation Program. Inspired by herbal medicine research two decades ago, the team has remained dedicated to R&D and, through effective technology transfer, has significantly advanced the development of an innovative new drug for diabetes. This journey—from academic research to industrial application—serves as an inspiring example for new students and young researchers, encouraging them to pursue innovation with courage and conduct research with diligence, ultimately creating greater social value and impact in the future.
Wen-Chin Yang